SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-17-004310
Filing Date
2017-01-27
Accepted
2017-01-27 16:15:48
Documents
1
Group Members
J.W. OPPORTUNITIES MASTER FUND, LTD.J.W. PARTNERS, L.P.JASON G. WILDJW GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v457656_sc13ga.htm SC 13G/A 129158
  Complete submission text file 0001144204-17-004310.txt   130911
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88022 | Film No.: 17553907
SIC: 2834 Pharmaceutical Preparations

Mailing Address 515 MADISON AVENUE SUITE 14B NEW YORK NY 10022
Business Address 515 MADISON AVENUE SUITE 14B NEW YORK NY 10022 212-446-5362
JW Asset Management, LLC (Filed by) CIK: 0001549738 (see all company filings)

IRS No.: 412123331 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A